JP2005511595A5 - - Google Patents

Download PDF

Info

Publication number
JP2005511595A5
JP2005511595A5 JP2003541839A JP2003541839A JP2005511595A5 JP 2005511595 A5 JP2005511595 A5 JP 2005511595A5 JP 2003541839 A JP2003541839 A JP 2003541839A JP 2003541839 A JP2003541839 A JP 2003541839A JP 2005511595 A5 JP2005511595 A5 JP 2005511595A5
Authority
JP
Japan
Prior art keywords
phenyl
hal
methanoyl
hydrazono
pyridazin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003541839A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005511595A (ja
JP5116940B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2002/011351 external-priority patent/WO2003039548A1/en
Publication of JP2005511595A publication Critical patent/JP2005511595A/ja
Publication of JP2005511595A5 publication Critical patent/JP2005511595A5/ja
Application granted granted Critical
Publication of JP5116940B2 publication Critical patent/JP5116940B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2003541839A 2001-11-05 2002-10-10 ヒドラゾノ−マロニトリル類 Expired - Fee Related JP5116940B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP01125455 2001-11-05
EP01125455.4 2001-11-05
PCT/EP2002/011351 WO2003039548A1 (en) 2001-11-05 2002-10-10 Hydrazono-malonitriles

Publications (3)

Publication Number Publication Date
JP2005511595A JP2005511595A (ja) 2005-04-28
JP2005511595A5 true JP2005511595A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 2012-10-04
JP5116940B2 JP5116940B2 (ja) 2013-01-09

Family

ID=8179075

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003541839A Expired - Fee Related JP5116940B2 (ja) 2001-11-05 2002-10-10 ヒドラゾノ−マロニトリル類

Country Status (19)

Country Link
US (2) US7141572B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP1441730B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JP5116940B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR100898894B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CN (1) CN1585641A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AR (1) AR040629A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) ATE335486T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU2002363368B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BR (1) BR0213683A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA2465746C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE60213841T2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES2268157T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HUP0401747A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MX (1) MXPA04004263A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MY (1) MY129491A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PL (1) PL369738A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
RU (1) RU2302412C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
WO (1) WO2003039548A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA200404387B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA82323C2 (uk) * 2002-08-09 2008-04-10 Меда Фарма Гмбх & Ко. Кг Нова комбінація глюкокортикоїду та pde-інгібітору для лікування респіраторних захворювань, алергічних захворювань, астми та хронічних обструктивних легеневих захворювань
DE60331367D1 (de) 2002-12-30 2010-04-01 Angiotech Int Ag Wirkstofffreisetzung von schnell gelierender polymerzusammensetzung
US20060083714A1 (en) * 2003-01-27 2006-04-20 Warner James M Combination of a pde iv inhibitor and a tnf-alpha antagonist
WO2004087641A1 (ja) * 2003-03-31 2004-10-14 Daiichi Pharmaceutical Co., Ltd. ヒドラゾン誘導体
AR049384A1 (es) * 2004-05-24 2006-07-26 Glaxo Group Ltd Derivados de purina
KR101358479B1 (ko) * 2005-04-19 2014-02-06 다케다 게엠베하 폐고혈압 치료용 로플루밀라스트
GB0514809D0 (en) 2005-07-19 2005-08-24 Glaxo Group Ltd Compounds
JP5066175B2 (ja) 2006-03-31 2012-11-07 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ ヒスタミンh4受容体のモジュレーターとしてのベンゾイミダゾール−2−イルピリミジンおよびピラジン
US9371311B2 (en) 2008-06-30 2016-06-21 Janssen Pharmaceutica Nv Benzoimidazol-2-yl pyrimidine derivatives
CN103705942B (zh) 2008-11-15 2016-08-24 麦林塔医疗有限公司 抗微生物组合物
US20120301463A1 (en) 2009-09-30 2012-11-29 President And Fellows Of Harvard College Methods for Modulation of Autophagy Through the Modulation of Autophagy-Enhancing Gene Products
US8440655B2 (en) * 2010-06-21 2013-05-14 Theracos, Inc. Combination therapy for the treatment of diabetes
US9452173B2 (en) 2013-01-31 2016-09-27 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
US9433680B2 (en) 2013-01-31 2016-09-06 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
US9446131B2 (en) 2013-01-31 2016-09-20 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
US8778365B1 (en) 2013-01-31 2014-07-15 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
WO2014128585A1 (en) 2013-02-19 2014-08-28 Pfizer Inc. Azabenzimidazole compounds as inhibitors of pde4 isozymes for the treatment of cns and other disorders
EP2964229B1 (en) 2013-03-06 2019-12-11 Janssen Pharmaceutica NV Benzoimidazol-2-yl pyrimidine modulators of the histamine h4 receptor
WO2015054359A1 (en) * 2013-10-08 2015-04-16 Ebadi Mark A Methods and compositions for symptomatic reflief of the common cold
JP6713982B2 (ja) 2014-07-24 2020-06-24 ファイザー・インク ピラゾロピリミジン化合物
JP6506833B2 (ja) 2014-08-06 2019-04-24 ファイザー・インク イミダゾピリダジン化合物
EP3268085A4 (en) 2015-03-13 2018-10-31 The Board of Trustees of The Leland Stanford Junior University Ltb4 inhibition to prevent and treat human lymphedema
US11116737B1 (en) 2020-04-10 2021-09-14 University Of Georgia Research Foundation, Inc. Methods of using probenecid for treatment of coronavirus infections

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8400863D0 (en) * 1984-01-13 1984-02-15 Smith Kline French Lab Chemical compounds
DE19632549A1 (de) * 1996-08-13 1998-02-19 Merck Patent Gmbh Arylalkanoylpyridazine
DE19826841A1 (de) 1998-06-16 1999-12-23 Merck Patent Gmbh Arylalkanoylpyridazine
DE19850701A1 (de) * 1998-11-04 2000-05-11 Merck Patent Gmbh Benzoylpyridazine
DE19932315A1 (de) * 1999-07-10 2001-01-11 Merck Patent Gmbh Benzoylpyridazine

Similar Documents

Publication Publication Date Title
JP2005511595A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP2004517813A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP2005539054A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
RU2006118325A (ru) Производные пиразина и их фармацевтическое применение
JP2009533351A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP2006512301A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP2002520309A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP2009543836A (ja) インドール化合物
JP2007534702A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP2009511511A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CN113121379B (zh) Ampk激动剂化合物或其药学上可接受的盐或酯或溶剂化物及其用途
JP2011507929A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA2447305A1 (fr) Nouveaux derives de 5-phenyl-1h-indole antagonistes des recepteurs de l'interleukine-8
FR2585019A1 (fr) Derives de distamycine et leur procede de fabrication
RU2008128566A (ru) Органические соединения
TW200846338A (en) Pyridyl imidazolidine derivative having sulfamoyl group, and pharmaceutical use thereof
CN112920208A (zh) 一种含硼酸的吲哚芳基砜类衍生物及其制备方法与应用
JP2009543837A (ja) Ep1受容体に対して親和性を有するインドール化合物
EP2113502B1 (fr) Composés de type hydrazide et leur utilisation dans des compositions pharmaceutiques pour le traitement des maladies cardiovasculaires
JP2011511053A (ja) ボリノスタットの新規な製造方法
JP2006522034A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
WO2003016313A1 (fr) Nouveaux composes de traitement de l'impuissance
US4107286A (en) Polyiods benzene derivatives and X-ray contrast media containing the same
WO2002092568A1 (fr) Derives de 5-cyano-1h-indole antagonistes des recepteurs de l'interleukine-8
JP2013503170A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)